US Patent Issued to PRILENIA NEUROTHERAPEUTICS on July 21 for "Pridopidine for the treatment of mitochondrial-associated diseases and disorders and endoplasmic reticulum (ER) stress" (Israeli, Portuguese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,725, issued on July 21, was assigned to PRILENIA NEUROTHERAPEUTICS LTD. (Yakum, Israel).

"Pridopidine for the treatment of mitochondrial-associated diseases and disorders and endoplasmic reticulum (ER) stress" was invented by Michael Hayden (Herzliya, Israel), Michal Geva (Even-Yehuda, Israel), Ana Cristina Carvalho Rego (Coimbra, Portugal) and Gerardo Lederkremer (Shoham, Portugal).

According to the abstract* released by the U.S. Patent & Trademark Office: "The subject invention provides a method for treating a subject afflicted with a disease, disorder, or condition associated with mitochondrial dysfunction or ER stress, comprising administering to the subject a composition com...